Entebbe Cohort

Year

Authors

Title

Journal

DOI / Reference

2002

Neil French, Katherine Gray, Christine Watera, Jessica Nakiyingi, Eric Lugada, Michael Moore, David Lalloo, James A. Whitworth, Charles F. Gilks

Cryptococcal infection in a cohort of HIV 1–infected Ugandan adults

AIDS

10.1097/00002030-200205030-00009 (PubMed)

2006

Watera, C.; Todd, J.; Muwonge, R.; Whitworth, J.; Nakiyingi Miiro, J.; Brink, A.; Miiro, G.; Antvelink, L.; Kamali, A.; French, N.; Mermin, J.

Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1–infected adults attending an HIV/AIDS clinic in Uganda

Journal of Acquired Immune Deficiency Syndromes

10.1097/01.QAI.0000221679.14445.1B (LSTM Research)

2007

J. N. Jarvis, et al.

Asymptomatic serum cryptococcal antigenemia and early mortality in a cohort of HIV 1-infected individuals

Tropical Medicine & International Health

10.1111/j.1365-3156.2007.01874.x (Wiley Online Library)

2007

Watera, C.; Todd, J. S.; Mutonyi, G.; Miiro, G.; Mpendo, J.; Hughes, P.; Nakiyingi Miiro, J.; Whitworth, J. A.; Grosskurth, H.

Effects of cotrimoxazole on hematologic parameters in HIV-infected adults in a community-based clinic in Entebbe, Uganda

Journal of Acquired Immune Deficiency Syndromes

10.1097/QAI.0b013e3181170c47 (CoLab)

2008

A. Kambugu, D. B. Meya, et al.

Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy

Clinical Infectious Diseases

(see PDF) (NRU UNCST)

2009

Miiro, G.; Todd, J. S.; Mpendo, J.; Watera, C.; Munderi, P.; Nakubulwa, S.; Kaddu, I.; Rutebarika, D.; Grosskurth, H.

Reduced morbidity and mortality in the first year after initiating highly active antiretroviral therapy (HAART) among Ugandan adults

Tropical Medicine & International Health

10.1111/j.1365-3156.2009.02259.x (NRU UNCST)

2011

E. J. Mills, C. Bakanda, J. Birungi, R. Mwesigwa, K. N. Chan, N. P. Ford, R. S. Hogg, C. Cooper

Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda

AIDS

10.1097/QAD.0b013e32834564e9 (MSF Science Portal)

2014

B. Masiira, …

Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm³ compared to the general population

Global Health Action

(full article) (Taylor & Francis Online)

2015

J. Rubaihayo, …

Trends and Predictors of Mortality Among HIV Positive Patients in the Era of HAART in Uganda

PLOS ONE

(PMC full text) (PMC)

2016

J. Rubaihayo, Nazarius M. Tumwesigye, Joseph Konde-Lule, Henry Wamani, Edith Nakku-Joloba, Fredrick Makumbi

Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda

BMC Research Notes

10.1186/s13104-016-2317-7 (BioMed Central)

2019

Jonathan Kitonsa, Yunia Mayanja, Emmanuel Aling, Julius Kiwanuka, Juliana Namutundu, Zacchaeus Anywaine, Abu-Baker Ggayi, Freddie Kibengo, Noah Kiwanuka, Pontiano Kaleebu

Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda

PLOS ONE

10.1371/journal.pone.0210287 (PLOS)

~2020

E. Mpoza, et al.

Cryptococcal Antigenemia in Human Immunodeficiency Virus

Clinical Infectious Diseases

(OUP article) (OUP Academic)

~2024

S. Walukaga, …

The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022

Medical Mycology

(PubMed)